{"component": "definition", "props": {"groups": [{"snippet_links": [{"key": "united-states", "type": "definition", "offset": [42, 55]}, {"key": "the-united-kingdom", "type": "clause", "offset": [64, 82]}], "snippet": "means any one of the following countries: United States, Japan, the United Kingdom, France, Germany, Italy or Spain.", "size": 128, "samples": [{"hash": "lfB0LK1f1sa", "uri": "/contracts/lfB0LK1f1sa#major-market", "label": "Patent License Agreement (Icosavax, Inc.)", "score": 32.5126609802, "published": true}, {"hash": "j8NFdXGrfh6", "uri": "/contracts/j8NFdXGrfh6#major-market", "label": "Patent License Agreement Nonexclusive \u2013 Sublicensable (Icosavax, Inc.)", "score": 32.364818573, "published": true}, {"hash": "9NkEdHWGBDM", "uri": "/contracts/9NkEdHWGBDM#major-market", "label": "License and Research Collaboration Agreement", "score": 31.3408622742, "published": true}], "hash": "44e2fe392ffd402dbecc06c31b36e78b", "id": 1}, {"snippet_links": [], "snippet": "means [***].", "size": 116, "samples": [{"hash": "7mMojG9XVDO", "uri": "/contracts/7mMojG9XVDO#major-market", "label": "License Agreement (Kardigan, Inc.)", "score": 37.3367556468, "published": true}, {"hash": "dWVeJPp67Rc", "uri": "/contracts/dWVeJPp67Rc#major-market", "label": "Asset Purchase Agreement (Kezar Life Sciences, Inc.)", "score": 37.1916503906, "published": true}, {"hash": "j6tyxwAQ8ZP", "uri": "/contracts/j6tyxwAQ8ZP#major-market", "label": "Purchase and Sale Agreement (Ligand Pharmaceuticals Inc)", "score": 35.5982208252, "published": true}], "hash": "42145ccc68badf480a8ed917c57dd5fc", "id": 2}, {"snippet_links": [{"key": "the-united-states", "type": "definition", "offset": [38, 55]}, {"key": "the-european-union", "type": "clause", "offset": [57, 75]}, {"key": "the-united-kingdom", "type": "clause", "offset": [85, 103]}], "snippet": "means, individually and collectively, the United States, the European Union, Canada, the United Kingdom, France, Germany, Italy, Spain, China and Japan.", "size": 95, "samples": [{"hash": "88ijwJS2Ds6", "uri": "/contracts/88ijwJS2Ds6#major-market", "label": "Cross License Agreement (Alnylam Pharmaceuticals, Inc.)", "score": 34.1444206238, "published": true}, {"hash": "Zh4StU0vP2", "uri": "/contracts/Zh4StU0vP2#major-market", "label": "Cross License Agreement", "score": 31.3408622742, "published": true}, {"hash": "anGAAfUrqce", "uri": "/contracts/anGAAfUrqce#major-market", "label": "Cross License Agreement (TEKMIRA PHARMACEUTICALS Corp)", "score": 24.2334022522, "published": true}], "hash": "f7b2f8a7dc22bddf02d005ccbab29c83", "id": 3}, {"snippet_links": [{"key": "the-united-states", "type": "definition", "offset": [6, 23]}, {"key": "major-european-countries", "type": "definition", "offset": [29, 53]}], "snippet": "means the United States, the Major European Countries and Japan.", "size": 63, "samples": [{"hash": "bMIOVtr18Br", "uri": "/contracts/bMIOVtr18Br#major-market", "label": "Collaboration and License Agreement (Exscientia LTD)", "score": 32.7097892761, "published": true}, {"hash": "iUNmoR2wqWA", "uri": "/contracts/iUNmoR2wqWA#major-market", "label": "Collaboration and License Agreement (Ambrx Biopharma Inc.)", "score": 32.4031486511, "published": true}, {"hash": "dCQF4sNilTb", "uri": "/contracts/dCQF4sNilTb#major-market", "label": "Collaboration and License Agreement (Ambrx Biopharma Inc.)", "score": 32.4031486511, "published": true}], "hash": "327035978cf2f928602b12414513c674", "id": 4}, {"snippet_links": [], "snippet": "means each of the [***].", "size": 62, "samples": [{"hash": "cuM3ApetxSx", "uri": "/contracts/cuM3ApetxSx#major-market", "label": "Collaboration and License Agreement (Vir Biotechnology, Inc.)", "score": 36.3483924866, "published": true}, {"hash": "2ANgLDCVJZ0", "uri": "/contracts/2ANgLDCVJZ0#major-market", "label": "Collaboration, Option and License Agreement (Merus N.V.)", "score": 35.3490753174, "published": true}, {"hash": "d5ao2dNOi8b", "uri": "/contracts/d5ao2dNOi8b#major-market", "label": "License Agreement (Roivant Sciences Ltd.)", "score": 32.4962348938, "published": true}], "hash": "6fa8af600a22198740752411722b705f", "id": 5}, {"snippet_links": [], "snippet": "means any of [***].", "size": 47, "samples": [{"hash": "4huTrMoOXBX", "uri": "/contracts/4huTrMoOXBX#major-market", "label": "License and Collaboration Agreement (Kailera Therapeutics, Inc.)", "score": 37.2327156067, "published": true}, {"hash": "4fBWihDWElc", "uri": "/contracts/4fBWihDWElc#major-market", "label": "Exclusive Research Collaboration, Option and License Agreement (Silence Therapeutics PLC)", "score": 34.1991767883, "published": true}, {"hash": "kWk1ab86y5e", "uri": "/contracts/kWk1ab86y5e#major-market", "label": "Exclusive Research Collaboration, Option and License Agreement (Silence Therapeutics PLC)", "score": 33.2053375244, "published": true}], "hash": "6bb4cb65c1e40e0e41a9568b11d406bd", "id": 6}, {"snippet_links": [], "snippet": "means any of the following countries: [***].", "size": 38, "samples": [{"hash": "7hMGGkEsXt0", "uri": "/contracts/7hMGGkEsXt0#major-market", "label": "Strategic Collaboration Agreement (Ionis Pharmaceuticals Inc)", "score": 36.5756340027, "published": true}, {"hash": "8iIu973sEfx", "uri": "/contracts/8iIu973sEfx#major-market", "label": "License and Collaboration Agreement (BioNTech SE)", "score": 35.2149200439, "published": true}, {"hash": "6vY4nP7xmDX", "uri": "/contracts/6vY4nP7xmDX#major-market", "label": "Collaboration and Option Agreement", "score": 35.0734024048, "published": true}], "hash": "f00dd30047b5830212179e1de82295fd", "id": 7}, {"snippet_links": [{"key": "the-united-kingdom", "type": "clause", "offset": [14, 32]}], "snippet": "means each of the United Kingdom, France, Germany, Spain or Italy.", "size": 25, "samples": [{"hash": "aH8hzAAIrwx", "uri": "/contracts/aH8hzAAIrwx#major-market", "label": "Contingent Payment Rights Agreement (Cubist Pharmaceuticals Inc)", "score": 22.9438743591, "published": true}, {"hash": "erWlQWg8Cus", "uri": "/contracts/erWlQWg8Cus#major-market", "label": "Merger Agreement (Cubist Pharmaceuticals Inc)", "score": 22.8480491638, "published": true}, {"hash": "c9ovJHrO49Y", "uri": "/contracts/c9ovJHrO49Y#major-market", "label": "Merger Agreement (Adolor Corp)", "score": 22.8124580383, "published": true}], "hash": "f5273dab9cda949fcc95d0b18c65a1e4", "id": 8}, {"snippet_links": [{"key": "the-united-states-of-america", "type": "clause", "offset": [6, 34]}, {"key": "the-european-union", "type": "clause", "offset": [36, 54]}], "snippet": "means the United States of America, the European Union or Japan.", "size": 18, "samples": [{"hash": "502aRTueJZI", "uri": "/contracts/502aRTueJZI#major-market", "label": "Exclusive License Agreement (Aridis Pharmaceuticals, Inc.)", "score": 31.893907547, "published": true}, {"hash": "lUxARgBBIhc", "uri": "/contracts/lUxARgBBIhc#major-market", "label": "Exclusive License and Research Collaboration Agreement (Metabasis Therapeutics Inc)", "score": 21.0, "published": true}, {"hash": "ePX5lywshZJ", "uri": "/contracts/ePX5lywshZJ#major-market", "label": "Exclusive License and Research Collaboration Agreement (Metabasis Therapeutics Inc)", "score": 21.0, "published": true}], "hash": "57bbec2103023d153f03d09e201d912a", "id": 9}, {"snippet_links": [{"key": "the-united-states-of-america", "type": "clause", "offset": [36, 64]}, {"key": "subject-to-the", "type": "definition", "offset": [102, 116]}, {"key": "authorisation-procedure", "type": "clause", "offset": [127, 150]}, {"key": "evaluation-agency", "type": "definition", "offset": [177, 194]}], "snippet": "means any one of the following: (i) the United States of America, (ii) any country in Europe which is subject to the Marketing Authorisation procedure of the European Medicines Evaluation Agency, or (iii) Japan.", "size": 16, "samples": [{"hash": "4t2otvzT1D3", "uri": "/contracts/4t2otvzT1D3#major-market", "label": "Collaboration Agreement (Elevation Oncology, Inc.)", "score": 32.364818573, "published": true}, {"hash": "dXYCvUHS7Nt", "uri": "/contracts/dXYCvUHS7Nt#major-market", "label": "Technology Transfer and License Agreement (Dyax Corp)", "score": 25.3312797546, "published": true}, {"hash": "2U9EjwXCLjP", "uri": "/contracts/2U9EjwXCLjP#major-market", "label": "Collaboration Agreement (Merrimack Pharmaceuticals Inc)", "score": 22.8151950836, "published": true}], "hash": "589ec57c426dd1ac02469e9f0c6389cf", "id": 10}], "next_curs": "ClkSU2oVc35sYXdpbnNpZGVyY29udHJhY3RzcjULEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIVbWFqb3ItbWFya2V0IzAwMDAwMDBhDKIBAmVuGAAgAA==", "definition": {"snippet": "means any one of the following countries: United States, Japan, the United Kingdom, France, Germany, Italy or Spain.", "size": 1085, "title": "Major Market", "id": "major-market", "examples": ["In the event that United Therapeutics determines that it will make no commercialization efforts with respect to Product in one or more <strong>Major Market</strong> Countries outside of the United States, either through its own endeavors or through those of its Affiliates and sublicensees, MannKind shall have the option, exercisable by written notice to United Therapeutics during the Term, to exclude one or more of such <strong>Major Market</strong> Countries (the \u201cExcluded Countries\u201d) from the Territory."], "related": [["major-markets", "Major Markets", "<strong>Major Markets</strong>"], ["major-market-country", "Major Market Country", "<strong>Major Market</strong> Country"], ["major-market-countries", "Major Market Countries", "<strong>Major Market</strong> Countries"], ["major-eu-country", "Major EU Country", "Major EU Country"], ["us-territory", "U.S. Territory", "U.S. Territory"]], "related_snippets": [], "updated": "2026-05-28T05:54:56+00:00"}, "json": true, "cursor": ""}}